Artivion, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$20.9M
57 notices · 545,690 sh
Oct 2025 to Oct 2026
Reported ·
$20.7M
64 sales · 0 buys
Oct 2025 to Sep 2026
The two figures cover different periods.
8 of 64 reported sales carry the 10b5-1 box. Together they are 1.11% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-10GREEN ANDREW M, SVP, Regulatory and Quality$286,657
Form 4, 2026-09-11: sold 11,480 at $24.97 Form 4 ↗
2026-09-03GREEN ANDREW M, SVP, Regulatory and Quality$38,842
2026-09-02GREEN ANDREW M, SVP, Regulatory and Quality$177,498
Form 4, 2026-09-04: sold 8,003 at $27.04 Form 4 ↗
2026-08-27Stanton Marshall S., SVP, Clinical & MD Affair$198,695
2026-08-19Mackin James P, President & CEO$2,053,100
Form 4, 2026-08-20: sold 70,000 at $28.96 Form 4 ↗
2026-08-14Berry Lance A, EVP, COO, CFO & Treasurer$20,413
Form 4, 2026-08-17: sold 715 at $28.55 Form 4 ↗
2026-08-14GREEN ANDREW M, SVP, Regulatory and Quality$17,586
Form 4, 2026-08-17: sold 616 at $28.55 Form 4 ↗
2026-06-11GREEN ANDREW M, SVP, Regulatory and Quality$910,753
Form 4, 2026-06-15: sold 44,001 at $20.70 Form 4 ↗
2026-03-04JEAN F HOLLOWAY, SVP, General Counsel$340,556
2026-03-03Berry Lance A, EVP, COO, CFO & Treasurer$238,591
Form 4, 2026-03-04: sold 6,316 at $37.78 Form 4 ↗
2026-03-03Davis John E, Chief Commercial Officer$172,748
Form 4, 2026-03-04: sold 4,573 at $37.78 Form 4 ↗
2026-03-03Holloway Jean F, SVP, General Counsel$145,172
Form 4, 2026-03-04: sold 12,805 at $37.93 Form 4 ↗
2026-03-03Stanton Marshall S., SVP, Clinical & MD Affair$81,180
Form 4, 2026-03-04: sold 2,149 at $37.78 Form 4 ↗
2026-03-03Mackin James P, President & CEO$675,692
Form 4, 2026-03-04: sold 17,887 at $37.78 Form 4 ↗
2026-03-03Horton Amy, VP, Chief Accounting Officer$34,036
Form 4, 2026-03-04: sold 901 at $37.78 Form 4 ↗
2026-03-02Holloway Jean F, SVP, General Counsel$83,008
Form 4, 2026-03-03: sold 2,183 at $38.02 Form 4 ↗
2026-03-02Mackin James P, President & CEO$566,989
Form 4, 2026-03-03: sold 14,911 at $38.02 Form 4 ↗
2026-03-02Davis John E, Chief Commercial Officer$105,861
Form 4, 2026-03-03: sold 2,784 at $38.02 Form 4 ↗
2026-03-02Horton Amy, VP, Chief Accounting Officer$24,374
Form 4, 2026-03-03: sold 641 at $38.02 Form 4 ↗
2026-03-02Berry Lance A, EVP, COO, CFO & Treasurer$196,893
Form 4, 2026-03-03: sold 5,178 at $38.02 Form 4 ↗
2026-03-02Stanton Marshall S., SVP, Clinical & MD Affair$57,532
Form 4, 2026-03-03: sold 1,513 at $38.02 Form 4 ↗
2026-02-24Davis John E, Chief Commercial Officer$74,063
2026-02-24Berry Lance A, EVP, COO, CFO & Treasurer$160,083
2026-02-24Holloway Jean F, SVP, General Counsel$59,536
2026-02-24Mackin James P, President & CEO$497,416
2026-02-24Stanton Marshall S., SVP, Clinical & MD Affair$44,937
2026-02-24Horton Amy, VP, Chief Accounting Officer$29,625
2026-02-23Horton Amy, VP, Chief Accounting Officer$65,064
Form 4, 2026-02-25: sold 2,561 at $36.97 Form 4 ↗
2026-02-23Mackin James P, President & CEO$787,909
Form 4, 2026-02-25: sold 34,898 at $36.83 Form 4 ↗
2026-02-23Holloway Jean F, SVP, General Counsel$115,732
Form 4, 2026-02-25: sold 4,747 at $36.92 Form 4 ↗
2026-02-23Davis John E, Chief Commercial Officer$141,818
Form 4, 2026-02-25: sold 5,848 at $36.92 Form 4 ↗
2026-02-23Berry Lance A, EVP, COO, CFO & Treasurer$187,223
Form 4, 2026-02-25: sold 9,466 at $36.69 Form 4 ↗
2026-02-23Stanton Marshall S., SVP, Clinical & MD Affair$91,075
Form 4, 2026-02-25: sold 3,682 at $36.94 Form 4 ↗
2025-12-15Davis John E, Chief Commercial Officer$225,554
Form 4, 2025-12-17: sold 5,000 at $45.11 Form 4 ↗
2025-12-08Horton Amy, VP, Chief Accounting Officer$203,081
Form 4, 2025-12-09: sold 4,572 at $44.42 Form 4 ↗
2025-12-03Mackin James P, President & CEO$1,405,695
Form 4, 2025-12-04: sold 30,921 at $45.46 Form 4 ↗
2025-12-03JEAN F HOLLOWAY, SVP, General Counsel$331,391
Form 4, 2025-12-04: sold 7,315 at $45.30 Form 4 ↗
2025-12-02Mackin James P, President & CEO$1,430,715
Form 4, 2025-12-03: sold 30,921 at $45.56 Form 4 ↗
2025-11-21Stanton Marshall S., SVP, Clinical & MD Affair$2,133,936
Form 4, 2025-11-24: sold 47,376 at $45.04 Form 4 ↗
2025-11-20Stanton Marshall S., SVP, Clinical & MD Affair$674,833
Form 4, 2025-11-24: sold 15,276 at $44.18 Form 4 ↗
2025-11-18ELIZABETH A HOFF, Director$189,413
Form 4, 2025-11-19: sold 4,200 at $45.10 Form 4 ↗
2025-11-17Davis John E, Chief Commercial Officer$288,817
2025-11-17Horton Amy, VP, Chief Accounting Officer$274,382
Form 4, 2025-11-18: sold 6,000 at $45.73 Form 4 ↗
2025-11-17Holloway Jean F, SVP, General Counsel$288,817
2025-11-14Holloway Jean F, SVP, General Counsel$287,685
Form 4, 2025-11-18: sold 12,787 at $45.09 Form 4 ↗
2025-11-14Davis John E, Chief Commercial Officer$285,575
Form 4, 2025-11-18: sold 12,787 at $44.92 Form 4 ↗
2025-11-13Horton Amy, VP, Chief Accounting Officer$159,679
Form 4, 2025-11-14: sold 3,482 at $45.86 Form 4 ↗
2025-11-13Holloway Jean F, SVP, General Counsel$264,190
Form 4, 2025-11-12: sold 12,960 at $45.82 Form 4 ↗
2025-11-13Mackin James P, President & CEO$1,568,812
Form 4, 2025-11-14: sold 34,210 at $45.86 Form 4 ↗
2025-11-13Stanton Marshall S., SVP, Clinical & MD Affair$228,971
Form 4, 2025-11-14: sold 4,993 at $45.86 Form 4 ↗
2025-11-13Davis John E, Chief Commercial Officer$300,968
Form 4, 2025-11-14: sold 6,563 at $45.86 Form 4 ↗
2025-11-11Stanton Marshall S., SVP, Clinical & MD Affair$114,492
Form 4, 2025-11-12: sold 2,566 at $44.62 Form 4 ↗
2025-11-11Holloway Jean F, SVP, General Counsel$461,800
2025-11-11Holloway Jean F, SVP, General Counsel$132,072
2025-11-10Mackin James P, President & CEO$784,400
Form 4, 2025-11-12: sold 17,580 at $44.62 Form 4 ↗
2025-11-10Horton Amy, VP, Chief Accounting Officer$79,823
Form 4, 2025-11-12: sold 1,789 at $44.62 Form 4 ↗